PTH holdings: all 54 positions
PTH held 54 positions as of Oct 13, 2026. Iovance Biotherapeutics Inc is the largest at 5.15%; the top 10 are 36.6% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Iovance Biotherapeutics Inc | IOVA | 5.15% |
| 2 | Tenet Healthcare Corp | THC | 3.87% |
| 3 | Natera Inc | NTRA | 3.83% |
| 4 | Guardant Health Inc | GH | 3.69% |
| 5 | Revolution Medicines Inc | RVMD | 3.69% |
| 6 | 10X Genomics Inc | TXG | 3.66% |
| 7 | Roivant Sciences Ltd | ROIV | 3.58% |
| 8 | Insmed Inc | INSM | 3.20% |
| 9 | Twist Bioscience Corp | TWST | 3.10% |
| 10 | Medpace Holdings Inc | MEDP | 2.86% |
| 11 | Hinge Health Inc | HNGE | 2.67% |
| 12 | Illumina Inc | ILMN | 2.56% |
| 13 | Exelixis Inc | EXEL | 2.49% |
| 14 | Protagonist Therapeutics Inc | PTGX | 2.35% |
| 15 | Halozyme Therapeutics Inc | HALO | 2.31% |
| 16 | Oscar Health Inc | OSCR | 2.29% |
| 17 | Charles River Laboratories International Inc | CRL | 2.16% |
| 18 | Travere Therapeutics Inc | TVTX | 2.16% |
| 19 | Relay Therapeutics Inc | RLAY | 2.15% |
| 20 | CareDx Inc | CDNA | 2.14% |
| 21 | PACS Group Inc | PACS | 2.12% |
| 22 | Axogen Inc | AXGN | 2.06% |
| 23 | Kymera Therapeutics Inc | KYMR | 1.76% |
| 24 | MBX Biosciences Inc | MBX | 1.75% |
| 25 | Dianthus Therapeutics Inc | DNTH | 1.73% |
| 26 | Corcept Therapeutics Inc | CORT | 1.70% |
| 27 | CG oncology Inc | CGON | 1.49% |
| 28 | Aveanna Healthcare Holdings Inc | AVAH | 1.46% |
| 29 | LifeStance Health Group Inc | LFST | 1.37% |
| 30 | HeartFlow Inc | HTFL | 1.34% |
| 31 | AtriCure Inc | ATRC | 1.33% |
| 32 | NeoGenomics Inc | NEO | 1.32% |
| 33 | Amneal Pharmaceuticals Inc | AMRX | 1.31% |
| 34 | Edgewise Therapeutics Inc | EWTX | 1.26% |
| 35 | Nuvation Bio Inc | NUVB | 1.24% |
| 36 | Nurix Therapeutics Inc | NRIX | 1.22% |
| 37 | National HealthCare Corp | NHC | 1.16% |
| 38 | Palvella Therapeutics Inc | PVLA | 1.13% |
| 39 | Pediatrix Medical Group Inc | MD | 1.11% |
| 40 | Absci Corp | ABSI | 1.10% |
| 41 | Eton Pharmaceuticals Inc | ETON | 1.09% |
| 42 | Pulse Biosciences Inc | PLSE | 1.07% |
| 43 | Clover Health Investments Corp | CLOV | 1.04% |
| 44 | uniQure NV | QURE | 1.00% |
| 45 | Inhibrx Biosciences Inc | INBX | 0.97% |
| 46 | Xencor Inc | XNCR | 0.96% |
| 47 | Alto Neuroscience Inc | ANRO | 0.94% |
| 48 | Guardian Pharmacy Services Inc | GRDN | 0.88% |
| 49 | Neogen Corp | NEOG | 0.86% |
| 50 | Immunome Inc | IMNM | 0.78% |
| 51 | Beta Bionics Inc | BBNX | 0.76% |
| 52 | Cullinan Therapeutics Inc | CGEM | 0.69% |
| 53 | Invesco Government & Agency Portfolio | AGPXX | 0.10% |
| 54 | Securities Lending - Bnym | 0.00% | |
| Cash and other net assets | −0.001% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of PTH, data as of Oct 13, 2026. https://etfiq.com/funds/pth/holdings/
ETFIQ. (Oct 13, 2026). Holdings of PTH. Retrieved from https://etfiq.com/funds/pth/holdings/
[Holdings of PTH (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/pth/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.